# Filing Detail

Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-21-000524
Filing Date
2021-01-22
Accepted
2021-01-22 16:13:05
Documents
11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS | 1356234
2 | GRAPHIC | g111280g04v42.jpg | GRAPHIC | 58189
3 | GRAPHIC | g111280g61a55.jpg | GRAPHIC | 84779
4 | GRAPHIC | g111280g71a90.jpg | GRAPHIC | 101211
5 | GRAPHIC | g111280g72v00.jpg | GRAPHIC | 102194
6 | GRAPHIC | g111280g80v00.jpg | GRAPHIC | 93723
7 | GRAPHIC | g111280g82v00.jpg | GRAPHIC | 98738
8 | GRAPHIC | g111280g82v01.jpg | GRAPHIC | 57983
9 | GRAPHIC | g111280g83v00.jpg | GRAPHIC | 64231
10 | GRAPHIC | g111280g85v00.jpg | GRAPHIC | 115628
11 | GRAPHIC | g111280g89n71.jpg | GRAPHIC | 57648
| Complete submission text file | 0000950123-21-000524.txt |  | 2474649

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
AgenTus Therapeutics, Inc. (Filer) CIK: 0001840229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: DRS | Act: 33 | File No.: 377-04074 | Film No.: 21545926
SIC: 2836 Biological Products, (No Diagnostic Substances)